Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma

Figure 1

Transcriptional levels of FAM83 family members in pancreatic ductal adenocarcinoma (PDAC). (a) Oncomine dataset analysis showed the numbers of datasets with significant transcriptional upregulated expression (red) or downregulated expression (blue). (b) GEPIA dataset analysis validated increased FAM83A, FAM83D, FAM83E, and FAM83H expression in PDAC tumor. The fold change cutoff was 1.5, and the value cutoff was 0.05. Transcriptional expression levels of FAM83 family members in PDAC are delineated with red highlights.

(a)

(b)